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The purpose of the present study was to evaluate the effi-
cacy and safety of bipolar transurethral prostatectomy
(TURP) using the Gyrus
TM PlasmaKinetic System compared
with conventional monopolar TURP. This study included 102
patients with benign prostatic hyperplasia (BPH) who under-
went TURP from January 2003 to March 2005. In all, 49
consecutive patients had bipolar and 53 had monopolar
TURP. All patients were assessed by preoperative and
postoperative International Prostate Symptom Score (IPSS),
uroflowmetry, transrectal ultrasonography, operative time,
weight of resected tissue, change in serum sodium and
hemoglobin, duration of catheter use, length of hospital stay,
and complication rates. Significant improvement was seen
postoperatively in both groups, and no difference was
observed in the resection time, weight of resected tissue,
change in serum sodium and hemoglobin, improvement of
IPSS and peak flow rate (Qmax), or complication rates over
the 12-month follow-up in both groups. There was, however,
a significant difference in duration of catheter use and
hospital stay. Duration of catheter use (2.28 days vs. 3.12
days) and hospital stay (3.52 days vs. 4.27 days) were shorter
in the bipolar group (p = 0.012 vs. p = 0.034, respectively).
Our results demonstrate that bipolar TURP using the Gyrus
TM
Plasma Kinetic System is as effective as conventional
monopolar TURP with the additional advantage of reduced
length of catheter use and hospital stay. Bipolar TURP is a
promising new technique that may prove to be a good
alternative to conventional TURP in the future.
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INTRODUCTION
There are numerous treatment alternatives
available for patients with bladder outlet obstruc-
tion (BOO) secondary to benign prostatic hyper-
plasia (BPH), including watchful waiting, pharma-
cological therapy, minimally invasive therapy,
transurethral resection (TURP), and open pros-
tatectomy. Despite the widespread use of medical
treatment, a significant proportion of patients
require surgical intervention.
1 TURP remains the
most frequently performed operation for men
with BPH,
2 despite the availability of numerous
minimally invasive alternatives, because these fail
to equal TURP and require costly instruments, a
steep learning curve, and long-term follow-up to
establish their efficacy and safety.
3-5
At the same time, TURP often requires ex-
tended Foley catheterization and hospital stays,
and is associated with various complications,
including bleeding, TUR syndrome, incontinence,
impotence, and urethral stricture. In conventional
TURP, most morbidities are related to the use of
nonelectrolyte irrigation fluid, monopolar current,
poor visibility due to bleeding, and mechanical
factors.
Recently, transurethral resection with bipolar
energy was introduced to overcome some of these
complications. Bipolar TURP results in less ther-
mal damage and better visibility, and most impor-
tantly, the ability to use physiologic saline for
irrigation.
The purpose of this study was to compare the
efficacy and safety of this newer bipolar TURP
using the Gyrus
TM PlasmaKinetic Tissue Manage-
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ment System (Gyrus Medical Ltd., Bucks, UK)
with conventional monopolar TURP over a
follow-up period of 12 months.
MATERIALS AND METHODS
This study included a total of 102 patients with
BPH who underwent TURP using the Gyrus
TM
PlasmaKinetic Tissue Management System (Gyrus
Medical Ltd., Bucks, UK) or conventional mono-
polar resectoscope between January 2003 and
March 2005. Forty-nine consecutive patients
underwent bipolar TURP using the Gyrus
TM
system and fifty-three consecutive patients under-
went monopolar TURP using the conventional
monopolar resectoscope. For inclusion, patients
were required to be older than 50 years with
symptomatic BPH requiring surgical intervention.
Patients were excluded if they had an abnormal
digital rectal examination (DRE), increased serum
prostate specific antigen (PSA), evidence of neuro-
genic bladder, urethral stricture, bladder stone or
tumor, or a history of prostate surgery.
All patients were preoperatively evaluated in
detail by medical history, physical examination
with DRE, multiple serum analyses including PSA,
uroflowmetry, and transrectal ultrasound (TRUS).
One expert surgeon performed all operations.
Bipolar TURP was performed with a 24 Fr. Karl
Storz (Tuttlingen, Germany) continuous flow
resectoscope using saline irrigation and the Gyrus
TM
PlasmaKinetic Tissue Management System. The
PlasmaKinetic device had a maximum power of
200 W and delivered a radio frequency wavelength
of 320-450 kHz and a voltage range of 254-350 V.
The TUR loop consisted of an 80/20 platinum/
iridium alloy electrode with the active and return
electrode on the same axis (axipolar) separated by
a ceramic insulator.
Conventional monopolar TURP was performed
with an ACMI (Southborough, MA, USA) 24 Fr.
resectoscope using Urion (Hwaseong, Korea)
irrigation.
At the end of the procedure, a 22 Fr. 3-way
Foley catheter was inserted. Saline irrigation was
continued at a rate sufficient to maintain a clear
returning fluid and the catheter was removed if
the urine was clear in the absence of irrigation.
The patient was subsequently given a voiding
trial and discharged from the hospital if voiding
spontaneously.
Serum electrolytes and hemoglobin were
measured after TURP. Resection time, weight of
resected tissue, duration of catheter use and hos-
pital stay, and presence of any complications were
documented in detail. Patients were observed at
1, 6 and 12 months after TURP to allow for the
detection of early and late complications, Interna-
tional Prostate Symptom Score (IPSS) assessment,
and uroflowmetry.
Statistical analysis was carried out using
Student's t-test, Mann-Whitney test and Chi-
square test. A p-value < 0.05 was considered to be
statistically significant. Statistical data are pres-
ented as mean ± SD.
RESULTS
Table 1 shows the characteristics of the 102
patients. The mean operative time was 72.6 ± 31.8
minutes in the bipolar group and 74.2 ± 26.6
minutes in the monopolar group (p = 0.451). With
bipolar resection, 14.1 ± 6.9g of prostatic tissue
was resected versus 13.7 ± 8.7g in the monopolar
group (p = 0.514). Postoperatively, there was no
statistical difference in the mean changes of hemo-
globin (Hb) and serum sodium between the two
groups (p = 0.278 and p = 0.51, respectively) (Table
2).
Mean catheter duration was 2.28 ± 1.37 days in
the bipolar group and 3.12 ± 0.69 days in the
monopolar group (p = 0.012). The hospital stay
was also shorter in the bipolar group (3.52 ± 2.55
days vs. 4.27 ± 1.89 days) (p = 0.034) (Table 2).
IPSS and peak flow rate (Qmax) improvements
at 1, 6 and 12 months were equal in the two
groups (Table 3).
In the early postoperative period, complications
were noted in three cases (6.1%) in the bipolar
group and four cases (7.5%) in the monopolar
group. One patient required blood transfusion
due to severe reduction in Hb (1.9%) and two
patients required a second operation for TUR
fulguration due to bleeding in the monopolar
group (3.8%). In the bipolar group, no patient
required blood transfusion and one patientTable 3. Preoperative and Postoperative Improvement of IPSS and Qmax (mL/s) at 1, 6 and 12 Months
Bipolar group* Monopolar group
IPSS Qmax IPSS Qmax
Preoperative 18.7 ± 4.5 8.7 ± 2.7 19.9 ± 4.8 8.4 ± 2.0
1 month 6.6 ± 4.9 17.4 ± 3.8 8.1 ± 4.3 16.9 ± 3.7
Improvement 12.1 ± 4.6 8.7 ± 4.5 11.8 ± 3.4 8.5 ± 3.9
6 months 6.5 ± 4.0 18.9 ± 3.1 7.7 ± 4.9 18.5 ± 4.3
Improvement 12.2 ± 4.1 10.2 ± 4.8 12.2 ± 5.5 10.2 ± 5.2
12 months 7.0 ± 4.6 18.8 ± 4.2 7.8 ± 4.4 18.6 ± 2.9
Improvement 11.7 ± 3.5 10.1 ± 5.1 12.1 ± 5.1 10.2 ± 3.5
Values are presented as mean ± SD.
IPSS, international prostate symptom score; Qmax, peak flow rate.
*p > 0.05 by Mann-Whitney test.
Bipolar TURP
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Table 2. Perioperative Data
Bipolar group Monopolar group p value
Weight of resected tissue (g) 14.1 ± 6.9 13.7 ± 8.7 0.514*
Operative time (min) 72.6 ± 31.8 74.2 ± 26.6 0.451*
Change in serum Na (mEq/L) 0.06 ± 3.63 -0.64 ± 3.56 0.51*
Fall in hemoglobin (g/dL) 0.67 ± 0.62 0.62 ± 0.78 0.278
Duration of catheter (days) 2.28 ± 1.37 3.12 ± 0.69 0.012*
Hospital stay (days) 3.52 ± 2.55 4.27 ± 1.89 0.034*
Values are presented as mean ± SD.
*p value by Mann-Whitney test.
p value by t-test.
Table 1. Patient Characteristic
Bipolar group Monopolar group p value
Number of patient 49 53 -
Age (years) 68.4 ± 7.8 69.6 ± 7.6 0.864
Prostate Volume (mL) 49.1 ± 20.5 47.3 ± 16.9 0.335
PSA (ng/mL) 2.89 ± 1.34 2.72 ± 0.91 0.273
Preop hemoglobin (g/dL) 12.6 ± 1.9 12.9 ± 2.1 0.635
Preop serum Na (mEq/L) 138.9 ± 3.4 139.1 ± 3.8 0.450
IPSS 18.7 ± 4.5 19.9 ± 4.8 0.673
QoL 4.1 ± 1.0 4.5 ± 1.2 0.765
Qmax (mL/sec) 8.7 ± 2.7 8.4 ± 2.0 0.866
Values are presented as mean ± SD.
IPSS, international prostate symptom score; QoL, quality of life; Qmax, peak flow rate.Chang-Jun Yoon, et al.
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required a second operation for TUR fulguration
due to bleeding (2.0%). Urinary tract infection
(UTI) was observed in two (4.1%) and one (1.9%)
patients in the bipolar and monopolar groups,
respectively (Table 4).
At 12 months, late postoperative complications
were noted in three cases (6.1%) in the bipolar
group and two (3.8%) cases in the monopolar
group. Urethral stricture was observed in two
(4.1%) and one (1.9%) patients in the biopolar and
monopolar groups, respectively. Urge inconti-
nence was observed in one (1.9%) patient in
monopolar group, and persistent obstructive
symptom was observed in one (2.0%) patient in
the bipolar group (Table 4).
DISCUSSION
BPH is a common problem that affects aging
men. Treatment of this condition includes medical
and surgical approaches. Despite the availability
of medical treatment, about twenty percent of
patients with symptomatic BPH require surgical
intervention.
1 Even with new advances in mini-
mally invasive techniques, TURP remains the
standard surgical therapy.
2 The large amount of
data currently available allows adequate assess-
ment of the efficacy of TURP compared with these
new minimally invasive techniques.
3-5
Conventional monopolar TURP is considered
safe with a low associated mortality rate. High
perioperative morbidity rates largely due to intra-
operative and postoperative hemorrhage or per-
foration, however, have been reported. Moreover,
TUR syndrome, caused by absorption of irrigation
fluid, has been known to occur.
6-8 Typically, TURP
is performed using a monopolar electric current
whose direction flows from the active electrode to
a ground. To avoid conduction of this electrical
energy to surrounding tissues, a nonconductive
irrigating solution is used which, when absorbed
in excess, may cause TUR syndrome. The reported
rates range from 0.18% to 10.9%, with Mebust and
his colleagues reporting an incidence of 2% in
conventional monopolar TURP.
9-11 The risk of
TUR syndrome increases with a larger prostate (>
45 g) or longer resection time (> 90 min).
Recently, transurethral resection and vapori-
zation with bipolar energy has been introduced as
a technical modification of TURP.
12-14 The biggest
advantage of bipolar current in TURP is the use
of saline for irrigation, which may reduce the
morbidity associated with the absorption of fluid.
Performing TURP with saline eliminates the risk
of TUR syndrome, thereby enabling the removal
of a large bulk of prostate tissue by resection or
vaporization.
In our results, the change in serum sodium
concentration was not significantly greater in the
monopolar resection group when compared to the
bipolar group (p = 0.51). In bipolar TURP, the
Table 4. Complications
Bipolar group* Monopolar group
Early postoperative complications 3 (6.1) 4 (7.5)
Severe fall of hemoglobin 0 (0.0) 1 (1.9)
Secondary hemorrhage 1 (2.0) 2 (3.8)
UTI 2 (4.1) 1 (1.9)
Late postoperative complications 3 (6.1) 2 (3.8)
Urethral stricture 2 (4.1) 1 (1.9)
Urge incontinence 0 (0.0) 1 (1.9)
Persistent obstructive symptom 1 (2.0) 0 (0.0)
Total 6 (12.2) 6 (11.3)
Values are presented as number (%).
*p > 0.05 by Chi-square test.Bipolar TURP
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change in serum sodium was 0.06 mEq/L, whereas
in the monopolar group, the mean change was
-0.64 mEq/L. Two patients of the monopolar
groups were found to have serum sodium levels
of less than 135 mEq/L (125 mEq/L and 130 mEq/
L respectively). Although these patients did not
develop symptoms, they were at risk for TUR
syndrome.
In conventional monopolar TURP, radiofre-
quency energy is directed into the tissue where
electrical resistance creates temperatures as high
as 400 . In bipolar TURP, however, radiofrequ-
ency energy converts a conductive medium (saline
irrigant) into a plasma field of highly ionized
particles that disrupt the organic molecular bonds
between the tissues. By directing the radiofrequ-
ency current from an active electrode to an
adjacent return electrode, tissue temperature is
reduced to 40-70 . The low temperatures of
bipolar TURP allow for minimal tissue damage.
15
The absence of a return current in bipolar
surgery also removes the risks of burns and car-
diac pacemaker problems.
Moreover, bipolar electrocautery seems to be
more efficient for removing tissue and simulta-
neously controlling bleeding when compared to
the monopolar procedure. Coagulation is also
accurate and effective, which decreases the time
for control of bleeding and improves intra-
operative vision. Wendt-Nordahl and co-workers
reported that bleeding rate was significantly
reduced using the bipolar resectoscope in their
ex-vivo experiments, compared to the monopolar
resection device.
14
Our results show that bipolar TURP was
equivalent to conventional monopolar TURP in
improvement of IPSS and urinary flow rates at 1,
6 and 12 months of follow-up. In addition to the
aforementioned advantages, bipolar TURP allows
more rapid catheter removal and a shorter
hospital stay. Botto and co-workers
12 reported a
mean hospital stay of only 2.2 days, and all
patients were discharged without a catheter, while
Eaton and Francis
13 reported that 85% of patients
were able to return home on the day of surgery
and have their catheters removed at 48 hours in
the bipolar TURP group. In another study, the
patients treated by Gyrus TURP had their catheter
removed a mean of 1.4 days earlier than the
standard group, improving patient comfort,
length of hospital stay, and costs.
16
Our results also show that both duration of
catheter use and hospital stay were significantly
shorter in the bipolar group (p = 0.012 and p =
0.034, respectively).
Other studies with bipolar TURP have reported
high rates of recatheterization and that irritative
symptoms were more common in the bipolar
group, probably as a result of edema secondary to
higher current with lower frequency exerted on
the tissue.
17 Urethral stricture formation was also
more commonly observed in the bipolar group.
Several risk factors, such as the use of higher
ablative energy or larger resectoscope diameter,
may account for increased urethral stricture
formation. Higher recatheterization rates with the
bipolar device were also described in a rando-
mized study by Dunsmuir and collegues.
15 Singh
and his collegues,
18 however, reported that post-
operative dysuria was less with bipolar TURP
than with monopolar TURP. This difference could
be attributed to the greater thermal damage and
formation of granulation tissue with monopolar
current. In our results, there was no difference in
the incidence of recatheterization, irritative symp-
toms, or postoperative dysuria between the two
groups.
We encountered six complications (12.2%) in the
monopolar and six (11.3%) in the bipolar group.
Only one patient in the monopolar group required
transfusion for secondary hemorrhage. With re-
gards to overall complication rates, there was no
significant difference between the two groups.
In conclusion, the bipolar transurethral pros-
tatectomy (TURP) using the Gyrus
TM Plasma
Kinetic System is as effective as conventional
monopolar TURP with the additional advantage
of decreased duration of catheter use and hospital
stay. Therefore, bipolar TURP is a promising new
technique that may prove to be a good alternative
to conventional TURP in the future.
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